ECMO Therapy Out of Reach for Multiple Socioeconomic Groups Sex, insurance status, and income all factors in access to advanced critical care therapy Apr 07, 2023
Timing of Pacemaker, ICD Infections Suggests Closer Wound Checks for Some Researchers stress early detection and treatment of CIED infection Apr 05, 2023
More Sophisticated Imaging Doesn't Necessarily Mean Better Outcomes in Ischemic HF But cardiac MRI, PET may still have value in some patients, per AIMI-HF trial Mar 09, 2023
Virtual Care Team Optimized Heart Failure Medications During Hospitalization Trial shows modest effect with daily recommendations to the treating team Mar 07, 2023
Minimally Invasive Mitral Valve Surgery Earns Confidence in Expert Hands Decision for mini thoracotomy may rest on patient preference, expert operator availability Mar 06, 2023
Hunt for Hibernating Myocardium Doesn't Help PCI for Ischemic Cardiomyopathy REVIVED-BCIS2 challenges long-held beliefs about myocardial viability Mar 05, 2023
Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
Women Still Face Higher Risks for Mortality After CABG Sex disparities in adverse outcomes, including death, didn't change in the last decade Mar 01, 2023
Omecamtiv Mecarbil for Heart Failure Turned Down by FDA End of the road for cardiac myosin activator Mar 01, 2023
Arrival of TEER Has Helped Surgeons' Track Records Nationwide analysis of technology's effect since FDA approval 10 years ago Feb 06, 2023
Fixing Heart Failure Workforce Issues: Baby Steps Start This Year Pay, curriculum changes proposed to attract more doctors Jan 05, 2023
The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs Treatment no longer limited by ejection fraction Dec 27, 2022
TAVR at 20: How Much Longer Will Medicare Mandate a Registry? Change is a-comin' but interventionalists debate just how soon that should be and what comes next Dec 08, 2022
Heart Failure From Meth Use: Growing Beast Lurks in the Shadows Exact scope of problem still unknown due to low clinician awareness Dec 02, 2022
Early Cardiac Amyloidosis Still Bad News Without Treatment Observational study supports treating even asymptomatic patients Nov 16, 2022
Upfront ECMO Disappoints for Cardiogenic Shock High-cost procedure not yet justified as an early strategy Nov 07, 2022
Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
Experts Agree Intravenous Iron Shows Promise for Heart Failure Patients While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the ED Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
Definitive Answer on Steroids for Infant Heart Surgery Falls Short STRESS trial misses primary endpoint but secondary benefits are suggestive Nov 06, 2022
Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysis Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022
Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study Nov 05, 2022
Empagliflozin Protects At-Risk Patients From CKD Progression Also cut risk for cardiovascular-related death and worsening kidney function Nov 04, 2022
Heart Failure Common in Cystic Fibrosis Patients Other frequent cardiac comorbidities included Afib and acute MI, real-world analysis shows Oct 18, 2022
Despite Exciting Newcomer Drugs, Uptake of HF Meds Still Meek Across Oceans U.S. not alone in slow initiation, low target-dose achievement, and early discontinuation Oct 14, 2022
Lower Entresto Doses Suffice in the Real World Reassuring findings for patients who don't tolerate the maximum ARNI dose Oct 10, 2022
FDA Approves At-Home Furosemide for Heart Failure Strong diuretic to become available outside the hospital setting Oct 10, 2022
Salt Pills During Diuresis: Acute HF Patients Neither Helped Nor Harmed Small randomized trial challenges conventional thinking about sodium Oct 05, 2022
Concurrent LAA Occlusion Loses Its Appeal for LVAD Surgeons Heart pump placement plus anticoagulation suffice for patients, even those with Afib Oct 05, 2022
The Search Is On for Another Xeno Heart Transplant Recipient Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER Data Analyses continue to support wider adoption of dapagliflozin, researchers say Oct 03, 2022
UNOS to Revamp Heart Allocation Rules to Rein in Transplant Waitlist Tricks It may be goodbye to priority tiers, hello to points-based ranking system in coming years Oct 03, 2022
Growing Calls to Marry HF Specialists With Cardiac Critical Care Cardiac ICU staffing issues require a multidisciplinary team approach, some say Oct 02, 2022
MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repair Post-approval study suggests growing pool of TEER-suitable patients Sep 18, 2022
Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven Large trial comes up short in proving a definitive benefit to debris filters Sep 17, 2022
Aggressive Alcohol Septal Ablation for HCM Holds Up, Pacemakers Notwithstanding Complication of ablation not associated with worse outcomes at 5 years Sep 14, 2022
Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet Approach beats coronary access through the thigh Aug 29, 2022
Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
